These dividend stocks could send you checks for a lifetime.
News & Analysis: AstraZeneca
Keep your eyes on these three hot diabetes stocks this month.
These aren't the largest players in the field, but they could take the lead faster than you think.
Find out how earnings helped these companies.
These income-generating businesses deserve a place in your portfolio.
The Chinese government just agreed to pay the bills on some cancer drugs that have been around a long time.
AstraZeneca and Celgene Corporation are both outstanding buys for long-term-oriented investors. Here's why.
This year's World Conference on Lung Cancer has some important presentations scheduled.
These three dividend stocks have qualities that make them worth owning for the long haul.
AZN earnings call for the period ending March 31, 2018.